Ignite Creation Date:
2024-05-05 @ 7:45 PM
Last Modification Date:
2024-10-26 @ 9:53 AM
Study NCT ID:
NCT00734305
Status:
COMPLETED
Last Update Posted:
2016-09-01
First Post:
2008-08-12
Brief Title:
Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
Sponsor:
Merrimack Pharmaceuticals
Organization:
Merrimack Pharmaceuticals
Organization Data
Organization:
Merrimack Pharmaceuticals
Class:
INDUSTRY
Study ID:
MM-121-01-100
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Merrimack Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Sanofi | INDUSTRY |